tiprankstipranks
Advertisement
Advertisement

Prenetics’ IM8 Secures Equity-Linked Multi-Year Supplement Partnership With Inter Miami CF

Story Highlights
  • On May 7, 2026, Prenetics’ IM8 became Inter Miami’s exclusive health supplements partner in a multi-year deal.
  • Inter Miami took its first-ever equity stake in a brand partner, deepening strategic alignment with Prenetics and IM8 globally.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Prenetics’ IM8 Secures Equity-Linked Multi-Year Supplement Partnership With Inter Miami CF

Claim 55% Off TipRanks

An announcement from Prenetics Group ( (PRE) ) is now available.

On May 7, 2026, Prenetics Global announced a multi-year deal making its IM8 brand the exclusive Official Health Supplements Partner of Inter Miami CF, the Major League Soccer club co-owned by David Beckham. The agreement embeds IM8 products such as Daily Ultimate Essentials, Daily Ultimate Longevity and The Beckham Stack into Inter Miami’s Florida Blue Training Center and club operations, while also granting IM8 branding in the team’s Nutritional Center and throughout the new Nu Stadium.

In a notable first for the club, Inter Miami is taking an equity stake in Prenetics as part of the partnership, signaling strong conviction in IM8’s growth prospects and aligning the financial interests of both organizations. The deal extends IM8’s reach via group player name, image and likeness rights for at least four Inter Miami players, prominent digital and in-stadium signage, fan-zone activations, and international marketing rights across IM8’s 40-plus country footprint, strengthening the supplement brand’s positioning in professional sports and enhancing Prenetics’ visibility among global football audiences and existing stakeholders.

The most recent analyst rating on (PRE) stock is a Buy with a $29.00 price target. To see the full list of analyst forecasts on Prenetics Group stock, see the PRE Stock Forecast page.

Spark’s Take on PRE Stock

According to Spark, TipRanks’ AI Analyst, PRE is a Neutral.

The score is driven by strong technical uptrend signals and a bullish earnings-call outlook with robust growth/margin targets and solid liquidity. These positives are tempered by weak underlying financial performance—continued losses and cash burn—and a valuation profile that offers limited support due to negative earnings.

To see Spark’s full report on PRE stock, click here.

More about Prenetics Group

Prenetics Global Limited (Nasdaq: PRE) is a health sciences company focused on human health and longevity, primarily through its flagship consumer brand IM8. IM8, co-founded with David Beckham, sells premium, science-backed daily nutrition supplements such as its all-in-one Daily Ultimate Essentials, and has rapidly expanded to more than 40 countries, surpassing $100 million in annualized recurring revenue within 11 months of its December 2024 launch.

Positioned at the high end of the consumer health and performance market, IM8 targets athletes and health-conscious consumers, with products that are NSF Certified for Sport and marketed in partnership with elite sports figures including NBA champion Giannis Antetokounmpo, World No. 1 tennis player Aryna Sabalenka and Formula 1 driver Ollie Bearman. The brand emphasizes replacing multiple supplements with a single formulation, underlining convenience, scientific validation, and global scalability as key competitive levers.

Average Trading Volume: 227,271

Technical Sentiment Signal: Buy

Current Market Cap: $267.6M

Learn more about PRE stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1